Literature DB >> 22936401

Correlation between TGF-β1 expression and proteomic profiling induced by severe acute respiratory syndrome coronavirus papain-like protease.

Shih-Wen Li1, Tsuey-Ching Yang, Lei Wan, Ying-Ju Lin, Fuu-Jen Tsai, Chien-Chen Lai, Cheng-Wen Lin.   

Abstract

Severe acute respiratory syndrome (SARS) coronavirus (SARS-CoV) papain-like protease (PLpro), a deubiquitinating enzyme, demonstrates inactivation of interferon (IFN) regulatory factor 3 and NF-κB, reduction of IFN induction, and suppression of type I IFN signaling pathway. This study investigates cytokine expression and proteomic change induced by SARS-CoV PLpro in human promonocyte cells. PLpro significantly increased TGF-β1 mRNA expression (greater than fourfold) and protein production (greater than threefold). Proteomic analysis, Western blot, and quantitative real-time PCR assays indicated PLpro upregulating TGF-β1-associated genes: HSP27, protein disulfide isomerase A3 precursor, glial fibrillary acidic protein, vimentin, retinal dehydrogenase 2, and glutathione transferase omega-1. PLpro-activated ubiquitin proteasome pathway via upregulation of ubiquitin-conjugating enzyme E2-25k and proteasome subunit alpha type 5. Proteasome inhibitor MG-132 significantly reduced expression of TGF-β1 and vimentin. PLpro upregulated HSP27, linking with activation of p38 MAPK and ERK1/2 signaling. Treatment with SB203580 and U0126 reduced PLpro-induced expression of TGF-β1, vimentin, and type I collagen. Results point to SARS-CoV PLpro triggering TGF-β1 production via ubiquitin proteasome, p38 MAPK, and ERK1/2-mediated signaling.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22936401     DOI: 10.1002/pmic.201200225

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  14 in total

1.  The proteasome as a druggable target with multiple therapeutic potentialities: Cutting and non-cutting edges.

Authors:  G R Tundo; D Sbardella; A M Santoro; A Coletta; F Oddone; G Grasso; D Milardi; P M Lacal; S Marini; R Purrello; G Graziani; M Coletta
Journal:  Pharmacol Ther       Date:  2020-05-19       Impact factor: 12.310

2.  The proteome of the infectious bronchitis virus Beau-R virion.

Authors:  Stuart D Dent; Dong Xia; Jonathan M Wastling; Benjamin W Neuman; Paul Britton; Helena J Maier
Journal:  J Gen Virol       Date:  2015-12       Impact factor: 3.891

3.  Proteome profile of swine testicular cells infected with porcine transmissible gastroenteritis coronavirus.

Authors:  Ruili Ma; Yanming Zhang; Haiquan Liu; Pengbo Ning
Journal:  PLoS One       Date:  2014-10-21       Impact factor: 3.240

4.  SARS Coronavirus Papain-Like Protease Inhibits the TLR7 Signaling Pathway through Removing Lys63-Linked Polyubiquitination of TRAF3 and TRAF6.

Authors:  Shih-Wen Li; Ching-Ying Wang; Yu-Jen Jou; Su-Hua Huang; Li-Hsin Hsiao; Lei Wan; Ying-Ju Lin; Szu-Hao Kung; Cheng-Wen Lin
Journal:  Int J Mol Sci       Date:  2016-05-05       Impact factor: 5.923

5.  SARS coronavirus papain-like protease induces Egr-1-dependent up-regulation of TGF-β1 via ROS/p38 MAPK/STAT3 pathway.

Authors:  Shih-Wein Li; Ching-Ying Wang; Yu-Jen Jou; Tsuey-Ching Yang; Su-Hua Huang; Lei Wan; Ying-Ju Lin; Cheng-Wen Lin
Journal:  Sci Rep       Date:  2016-05-13       Impact factor: 4.379

6.  SARS coronavirus papain-like protease up-regulates the collagen expression through non-Samd TGF-β1 signaling.

Authors:  Ching-Ying Wang; Chien-Yi Lu; Shih-Wen Li; Chien-Chen Lai; Chun-Hung Hua; Su-Hua Huang; Ying-Ju Lin; Mann-Jen Hour; Cheng-Wen Lin
Journal:  Virus Res       Date:  2017-04-13       Impact factor: 3.303

Review 7.  Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19.

Authors:  Valentino Clemente; Padraig D'Arcy; Martina Bazzaro
Journal:  Int J Mol Sci       Date:  2020-05-15       Impact factor: 5.923

Review 8.  Why All the Fury over Furin?

Authors:  Essam Eldin A Osman; Alnawaz Rehemtulla; Nouri Neamati
Journal:  J Med Chem       Date:  2021-08-02       Impact factor: 7.446

Review 9.  Natural products as home-based prophylactic and symptom management agents in the setting of COVID-19.

Authors:  Sai Manohar Thota; Venkatesh Balan; Venketesh Sivaramakrishnan
Journal:  Phytother Res       Date:  2020-08-17       Impact factor: 6.388

Review 10.  Viruses as key modulators of the TGF-β pathway; a double-edged sword involved in cancer.

Authors:  Habibollah Mirzaei; Ebrahim Faghihloo
Journal:  Rev Med Virol       Date:  2018-01-18       Impact factor: 6.989

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.